Fergelot, P., Van Belzen, M., Van Gils, J., Afenjar, A., Armour, C. M., Arveiler, B., Beets, L., Burglen, L., Busa, T., Collet, M., Deforges, J., de Vries, B. B. A., Dominguez Garrido, E., Dorison, N., Dupont, J., Francannet, C., Garciá‐Minaúr, S., Gabau Vila, E., Gebre‐Medhin, S., Gener Querol, B., Geneviève, D., Gérard, M., Gervasini, C. G., Goldenberg, A., Josifova, D., Lachlan, K., Maas, S., Maranda, B., Moilanen, J. S., Nordgren, A., Parent, P., Rankin, J., Reardon, W., Rio, M., Roume, J., Shaw, A., Smigiel, R., Sojo, A., Solomon, B., Stembalska, A., Stumpel, C., Suarez, F., Terhal, P., Thomas, S., Touraine, R., Verloes, A., Vincent‐Delorme, C., Wincent, J., Peters, D. J. M., Bartsch, O., Larizza, L., Lacombe, D., & Hennekam, R. C. (2016). phenotype and genotype in 52 patients with Rubinstein–Taybi syndrome caused by EP300 mutations. American journal of medical genetics, 170(12), 3069–3082. http://access.bl.uk/ark:/81055/vdc_100039241673.0x00000d